CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced today that on November 28, 2007 it will be presenting at the 19th Annual Piper Jaffray Healthcare Conference at 1:00 pm EST and the Lazard Capital Markets Fourth Annual Healthcare Conference at 2:30 pm EST, both in New York.
